Orbactiv Injection, Powder, Lyophilized, For Solution
Product Images NDC 70842-140

3 FDA label images from Melinta Therapeutics, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Orbactiv (NDC 70842-140). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Melinta Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Orbactiv 01)

Chemical Structure (Orbactiv 01)
Chemical structure of oritavancin, the active ingredient in Orbactiv 400 mg intravenous injection, powder, lyophilized for solution.*
FDA Label Image

Principal Display Panel (400 mg Vial Label)

Principal Display Panel (400 mg Vial Label)
Packaging label for Orbactiv (oritavancin) for injection, 400 mg per vial, powder for intravenous infusion only. The label indicates a single-dose vial with unused portions to be discarded. Marketed by Melinta Therapeutics, LLC. Contains instructions for reconstitution and dilution, and a note that the package contains three 400 mg single-dose vials.*
FDA Label Image

Principal Display Panel (400 mg Vial Carton)

Principal Display Panel (400 mg Vial Carton)
Orbactiv (oritavancin) for injection 400 mg per vial is a lyophilized powder for intravenous infusion. The label indicates it is a single-dose vial with instructions to discard any unused portion. The product is marketed by Melinta Therapeutics, LLC. The packaging includes details on reconstitution, dilution, and storage, and states the carton contains three 400 mg single-dose vials.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.